Deciphera Pharmaceuticals (DCPH) Reports Publication of INTRIGUE Phase 3 Clinical Study Results
Go back to Deciphera Pharmaceuticals (DCPH) Reports Publication of INTRIGUE Phase 3 Clinical Study Results(NASDAQ: DCPH) | Delayed: 14.73 +0.06 (0.41%) | |||||
---|---|---|---|---|---|---|
Previous Close | $14.67 | 52 Week High | $ | |||
Open | $14.70 | 52 Week Low | $ | |||
Day High | $14.84 | P/E | N/A | |||
Day Low | $14.61 | EPS | $ | |||
Volume | 22,406 |